Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression

被引:32
|
作者
Hen-Shoval, D. [1 ,2 ]
Amar, S. [3 ]
Shbiro, L. [2 ]
Smoum, R. [4 ]
Haj, Christeene G. [4 ]
Mechoulam, R. [4 ]
Zalsman, G. [5 ,6 ]
Weller, A. [1 ,2 ]
Shoval, G. [5 ,6 ]
机构
[1] Bar Ilan Univ, Psychol Dept, Ramat Gan, Israel
[2] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel
[3] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel
[4] Hebrew Univ Jerusalem, Med Fac, Inst Drug Res, IL-91120 Jerusalem, Israel
[5] Geha Mental Hlth Ctr, Petah Tiqwa, Israel
[6] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
Major depression disorder (MDD); Cannabidiolic acid methyl ester; Genetic animal models of depression; Wistar-Kyoto (WKY); Flinders Sensitive Line (FSL); Forced swim test (FST); RAT MODEL; CANNABINOIDS; INVOLVEMENT; RECEPTORS; ANXIETY; NAUSEA; MICE;
D O I
10.1016/j.bbr.2018.05.027
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background and purpose: Cannabidiolic acid methyl ester (HU-580) was recently shown to reduce stress-induced anxiety-like behavior in rats. The aim of this study was to examine the antidepressant effect of HU-580 in two different rat models of depression. Experimental approach: Using the forced swim test (FST), we evaluated the effect of HU-580 in 43 Wistar Kyoto (WRY) and 23 Flinders Sensitive Line (FSL) adult male rats. Key results: 1 mg/kg HU-580 reduced immobility and increased swimming in WKY rats, compared to vehicle treated controls (p < 0.05). This dose exerted similar effects in FSL rats (p < 0.05). Conclusion and implications: This is the first report of antidepressant efficacy of HU-580. These findings expand the very limited existent results, suggesting that HU-580 is a potent anxiolytic agent. Taken together with its chemical stability, HU-580 emerges as a candidate for a future antidepressant medication.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [21] A Tellurium-Based Small Immunomodulatory Molecule Ameliorates Depression-Like Behavior in Two Distinct Rat Models
    Hagar, Moshe
    Roman, Gersner
    Eitan, Okun
    Noam, Barnea-Ygael
    Abrham, Zangen
    Benjamin, Sredni
    NEUROMOLECULAR MEDICINE, 2020, 22 (03) : 437 - 446
  • [22] Chronic corticosterone exposure reduces hippocampal glycogen level and induces depression-like behavior in mice
    Zhang, Hui-yu
    Zhao, Yu-nan
    Wang, Zhong-li
    Huang, Yu-fang
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2015, 16 (01): : 62 - 69
  • [23] Evidence for dissociation between spontaneous pain and depression-like behavior in neuropathic pain models
    Laumet, G.
    Dantzer, R.
    Heijnen, C. J.
    Kavelaars, A.
    BRAIN BEHAVIOR AND IMMUNITY, 2016, 57 : E11 - E11
  • [24] Antidepressant-like activity of amisulpride in two animal models of depression
    Papp, M
    Wieronska, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (01) : 46 - 52
  • [25] Divergent maternal behavioral patterns in two genetic animal models of depression
    Braw, Y.
    Malkesman, O.
    Merenlender, A.
    Dagan, M.
    Bercovich, A.
    Lavi-Avnon, Y.
    Weller, A.
    PHYSIOLOGY & BEHAVIOR, 2009, 96 (02) : 209 - 217
  • [26] Evaluation of two genetic animal models in behavioral tests of anxiety and depression
    Hinojosa, FR
    Spricigo, L
    Izídio, GS
    Brüske, GR
    Lopes, DM
    Ramos, A
    BEHAVIOURAL BRAIN RESEARCH, 2006, 168 (01) : 127 - 136
  • [27] Knockdown of miR-124 Reduces Depression-like Behavior by Targeting CREB1 and BDNF
    Yang, Wei
    Liu, Min
    Zhang, Qianwei
    Zhang, Jiahua
    Chen, Jun
    Chen, Qiaoyun
    Suo, Lixia
    CURRENT NEUROVASCULAR RESEARCH, 2020, 17 (02) : 196 - 203
  • [28] Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models
    Scheich, Balint
    Gaszner, Balazs
    Kormos, Viktoria
    Laszlo, Kristof
    Adori, Csaba
    Borbely, Eva
    Hajna, Zsofia
    Tekus, Valeria
    Boelcskei, Kata
    Abraham, Istvan
    Pinter, Erika
    Szolcsanyi, Janos
    Helyes, Zsuzsanna
    NEUROPHARMACOLOGY, 2016, 101 : 204 - 215
  • [29] Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior
    Eskelund, Amanda
    Li, Yan
    Budac, David P.
    Muller, Heidi K.
    Gulinello, Maria
    Sanchez, Connie
    Wegener, Gregers
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 (01) : 118 - 131
  • [30] Hyperaldosteronism in an Animal Model - Changes in Depression-Like Behavior and Gene Expression Relevant to Major Depressive Disorder
    Jezova, Daniela
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 126S - 126S